Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Markus Renschler, MD
Pharmacyclics LLC.
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Cancer Care Ontario-Hamilton Regional Cancer Centre
Hamilton, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Montreal General Hospital
Montreal, Quebec, Canada
- Marin Oncology Associates, Inc.
Greenbrae, California, United States
- Beckman Research Institute, City of Hope
Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center, Ucla
Los Angeles, California, United States
- Kaiser Permanente Medical Group
Los Angeles, California, United States
- Radiation Oncology Center - Sacramento
Sacramento, California, United States
- University of Colorado Cancer Center
Denver, Colorado, United States
- Charlotte County Radiation Therapy Regional Center
Port Charlotte, Florida, United States
- Emory Clinic
Atlanta, Georgia, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Hematology and Oncology Services - Metairie
Metairie, Louisiana, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- Harper Hospital and Wayne State University
Detroit, Michigan, United States
- North Memorial Research Center
Minneapolis, Minnesota, United States
- Veterans Affairs Medical Center - Minneapolis
Minneapolis, Minnesota, United States
- Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- New Mexico Oncology-Hematology
Albuquerque, New Mexico, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Barrett Cancer Center, the University Hospital
Cincinnati, Ohio, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Abington Hematology Oncology Associates
Meadowbrook, Pennsylvania, United States
- Kimmel Cancer Center of Thomas Jefferson University - Philadelphia
Philadelphia, Pennsylvania, United States
- Presbyterian-University Hospital
Pittsburgh, Pennsylvania, United States
- Mercy Hospital Cancer Center - Scranton
Scranton, Pennsylvania, United States
- Thompson Cancer Survival Center
Knoxville, Tennessee, United States
- Vanderbilt Cancer Center
Nashville, Tennessee, United States
- University of Texas - Md Anderson Cancer Center
Houston, Texas, United States
- Scott and White Memorial Hospital
Temple, Texas, United States
- Virginia Mason Medical Center
Seattle, Washington, United States
- University of Wisconsin Comprehensive Cancer Center
Madison, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 1998
- Primary completion
- 30 Sept 2001
- Completion
- 30 Jun 2005
- Last update posted
- 31 Oct 2013
- Registered enrollment
- 430
- Registry id
- NCT00003563
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.